AMORIM CUNHA, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 549
EU - Europa 419
AS - Asia 201
SA - Sud America 6
OC - Oceania 1
Totale 1.176
Nazione #
US - Stati Uniti d'America 549
IT - Italia 119
IE - Irlanda 93
SG - Singapore 70
UA - Ucraina 64
CN - Cina 52
HK - Hong Kong 50
DE - Germania 32
SE - Svezia 30
FI - Finlandia 21
VN - Vietnam 15
RO - Romania 13
RU - Federazione Russa 13
CZ - Repubblica Ceca 10
FR - Francia 8
GB - Regno Unito 5
KR - Corea 5
BR - Brasile 4
LB - Libano 4
PL - Polonia 3
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
TR - Turchia 2
UZ - Uzbekistan 2
CL - Cile 1
CO - Colombia 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NZ - Nuova Zelanda 1
Totale 1.176
Città #
Chandler 125
Dublin 93
Perugia 74
San Mateo 64
Singapore 57
Hong Kong 50
Jacksonville 39
Boardman 30
Altamura 24
Santa Clara 23
Medford 21
Princeton 21
Beijing 20
Lawrence 18
Dong Ket 15
Wilmington 14
Ann Arbor 13
Bucharest 13
Des Moines 12
Andover 11
Brno 9
Munich 5
Seoul 5
Chicago 4
Guangzhou 4
Redwood City 4
Helsinki 3
Norwalk 3
Saint Petersburg 3
San Diego 3
San Paolo di Civitate 3
Brussels 2
Dearborn 2
Deruta 2
Izmir 2
Los Angeles 2
Miami 2
Redmond 2
Stockholm 2
Amsterdam 1
Auckland 1
Bogotá 1
Bologna 1
Changchun 1
Cormeilles-en-Parisis 1
Dallas 1
Edinburgh 1
Falls Church 1
Frankfurt Am Main 1
Hanover 1
Hefei 1
Houston 1
Lausanne 1
Moscow 1
Nuremberg 1
Olomouc 1
Praia Grande 1
Shanghai 1
Shenyang 1
Shenzhen 1
Simi Valley 1
Tappahannock 1
Tianjin 1
Verona 1
Vientiane 1
Totale 825
Nome #
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 96
Dectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis. 89
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 84
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. 76
CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. 67
IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis 64
Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. 60
Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC 60
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 59
Host genetics and invasive fungal diseases: towards improved diagnosis and therapy? 59
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis 58
Inflammation in aspergillosis: the good, the bad and the therapeutic 57
Genetic variability of innate immunity impacts human susceptibility to fungal diseases. 56
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. 54
Immunity and tolerance to infections in experimental hematopoietic transplantation 52
Genetic variability of innate immunity impacts human susceptibility to fungal diseases. 50
Cracking the Toll-like receptor code in fungal infections. 50
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 44
DAMP signaling in fungal infections and diseases 37
TLR9 Activation Dampens the Early Inflammatory Response to Paracoccidioides brasiliensis, Impacting Host Survival. 32
PTX3 deficiency and aspergillosis 31
Totale 1.235
Categoria #
all - tutte 5.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 3 20 8 12 6
2020/2021146 0 12 2 11 54 6 12 3 12 5 13 16
2021/2022177 1 47 2 5 6 4 0 58 1 5 19 29
2022/2023384 21 71 13 25 38 46 0 18 122 1 24 5
2023/2024141 11 14 7 2 0 0 36 0 14 2 25 30
2024/2025164 11 23 11 19 32 25 26 17 0 0 0 0
Totale 1.235